Wholesale investors onlyAny offer of financial products referred to on this page is available only to wholesale investors within the meaning of Schedule 1 of the Financial Markets Conduct Act 2013 and is not available to retail investors. This page provides general information only and is not financial advice or a formal offer.
Investment Opportunity
Building a New Zealand Biomaterials Platform for Global Markets.
Materially Kiwi is developing a platform that creates higher-value material pathways from kiwifruit and horticultural side streams, beginning with premium leather-like materials.
We are raising a NZ$750,000 seed round to advance formulation, front-end processing, performance validation and pilot-scale readiness.
The Opportunity
More Value From Resources That Already Exist
New Zealand produces hundreds of thousands of tonnes of kiwifruit each year. Fruit and processing side streams that do not reach consumers create an opportunity for new manufacturing value, regional capability and lower-impact material inputs.
Figures are indicative and provided for investor discussion. Technical, market and commercial assumptions remain subject to validation as development progresses.
Why Materially Kiwi
A Platform, Not a Single Product
The opportunity extends beyond one coated sheet. The front-end processing strategy is intended to create more consistent plant-based inputs and several potential value streams.
Existing Feedstock
The platform begins with horticultural side streams already generated within New Zealand’s established kiwifruit industry.
Multiple Pathways
Recovered plant-based fractions may support coated sheets, compounds and other future biomaterial formats as the science develops.
Premium Entry Market
Contemporary fashion and accessories offer a focused first market, with longer-term pathways into interiors and mobility applications.
Scalable Manufacturing Logic
The commercial pathway is being designed around established coating, drying and finishing capabilities rather than building an entirely new materials industry from zero.
Progress and Validation
Built Through Research, Market Learning and Persistence
Materially Kiwi has progressed from founder experimentation into structured research and commercial development, while retaining its intellectual property within the company.
- 01
Science Collaboration
Research and development collaboration with Scion, part of New Zealand’s Bioeconomy Science Institute.
- 02
Non-Dilutive Support
Support received through AGMARDT, the Bioresource Processing Alliance and Callaghan Innovation, alongside founder investment and in-kind contributions.
- 03
Market Interest
Inbound interest from more than 80 brands, with expressions of interest spanning New Zealand, Australia and Europe.
- 04
Recognition
Selected for climate and agritech programmes, featured by national media and included in The Earthshot Prize portfolio following nomination.
Commercial Pathway
From Side Stream to High-Value Material Inputs
The initial commercial focus is a premium backed and coated sheet for fashion and accessories. Over time, the platform may create additional revenue pathways through refined plant-based fractions, formulations, licensing, manufacturing partnerships or material supply.
The final model will be shaped by technical validation, pilot economics, manufacturing partnerships and market requirements.
Review the Material PlatformSource
Work with horticultural side streams and supply partners.
Refine
Separate and prepare useful plant-based components.
Develop
Formulate and validate material inputs and finished formats.
Commercialise
Scale through manufacturing, brand and market partnerships.
Use of Funds
What the Seed Round Unlocks
The raise is designed to move Materially Kiwi through its next technical and commercial de-risking milestones.
Fractionation and Formulation
Advance front-end processing, refine formulations and improve material consistency.
Testing and Validation
Complete relevant mechanical, durability and application-specific performance testing.
Pilot-Scale Planning
Progress equipment, manufacturing, process-flow and scale-up requirements.
Sample Development
Create larger, repeatable samples for structured partner and brand evaluation.
Commercial Readiness
Develop partnerships, economics, supply-chain planning and market-entry preparation.
Capability and IP
Strengthen specialist capacity and continue protecting valuable company know-how.
An Honest View of Stage
Early Enough to Shape. Advanced Enough to See the Path.
Materially Kiwi remains a development-stage company. The fractionation platform, formulations, performance data, production economics and route to scale are still being refined and validated.
That creates both risk and opportunity. The right investors can contribute more than capital through materials, manufacturing, market-entry and scale-up experience.
Detailed technical information, financial assumptions and confidential partnership material are available through an appropriate investor process.
Invest in the Next Chapter
Let’s Explore the Opportunity Together
We welcome conversations with aligned investors who understand deep-tech development, bioeconomy platforms and the value of patient, evidence-led scale.
Request an Investor Conversation